NuCana to Present at the Jefferies Virtual London Healthcare Conference
November 12, 2020 16:01 ET
|
NuCana plc
EDINBURGH, United Kingdom, Nov. 12, 2020 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will...
NuCana Expands its Board of Directors with the Appointment of Bali Muralidhar
October 13, 2020 16:01 ET
|
NuCana plc
EDINBURGH, United Kingdom, Oct. 13, 2020 (GLOBE NEWSWIRE) -- NuCana plc, a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer,...
NuCana Presents Three Posters at the ESMO Virtual Congress 2020
September 21, 2020 16:02 ET
|
NuCana plc
Encouraging Efficacy Signals Observed in Heavily Pre-Treated Patients with Metastatic Colorectal Cancer in the Phase Ib Study of NUC-3373 (NuTide:302) NUC-3373’s Favorable Pharmacokinetic and...
NuCana Announces Closing of Public Offering of American Depositary Shares and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares
September 21, 2020 16:01 ET
|
NuCana plc
EDINBURGH, United Kingdom, Sept. 21, 2020 (GLOBE NEWSWIRE) -- NuCana plc, a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer,...
NuCana Announces Pricing of a Public Offering of American Depositary Shares
September 17, 2020 07:00 ET
|
NuCana plc
EDINBURGH, United Kingdom, Sept. 17, 2020 (GLOBE NEWSWIRE) -- NuCana plc, a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer,...
NuCana Announces Proposed Public Offering of American Depositary Shares
September 16, 2020 16:01 ET
|
NuCana plc
EDINBURGH, United Kingdom, Sept. 16, 2020 (GLOBE NEWSWIRE) -- NuCana plc, a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer,...
NuCana Reports Second Quarter 2020 Financial Results and Provides Business Update
August 19, 2020 16:01 ET
|
NuCana plc
EDINBURGH, United Kingdom, Aug. 19, 2020 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced financial results for the second quarter ended June 30, 2020 and provided an update on its broad...
NuCana to Present at the 2020 Jefferies Virtual Healthcare Conference
May 27, 2020 07:00 ET
|
NuCana plc
EDINBURGH, United Kingdom, May 27, 2020 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will...
NuCana Reports First Quarter 2020 Financial Results and Provides Business Update
May 19, 2020 16:01 ET
|
NuCana plc
Clinical Studies Re-Opened to New Patient Enrollment Following Temporary Pause Due to COVID-19 Pandemic Numerous Clinical Data Announcements Expected in 2020 Cash and Cash...
NuCana Announces the Re-Opening of Enrollment in Multiple Clinical Studies After Temporary Pause Due to COVID-19 Pandemic
May 18, 2020 07:00 ET
|
NuCana plc
EDINBURGH, United Kingdom, May 18, 2020 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced it has re-commenced enrollment of new patients in multiple clinical studies following the temporary...